Apex Capital Management - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 149 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
Apex Capital Management ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$74,482,000
+7.2%
1,723,714
+4.9%
1.68%
+13.5%
Q2 2015$69,468,000
+16.5%
1,643,830
+6.9%
1.48%
+5.7%
Q1 2015$59,638,000
+55.4%
1,537,867
+34.9%
1.40%
+37.3%
Q4 2014$38,371,000
+4.5%
1,139,629
+8.7%
1.02%
-7.6%
Q3 2014$36,720,000
+13.5%
1,048,531
+6.5%
1.11%
+11.3%
Q2 2014$32,355,000
+0.2%
984,630
+12.3%
1.00%
-12.9%
Q1 2014$32,306,000
+3.5%
876,439
+7.8%
1.14%
-2.2%
Q4 2013$31,209,000
+1319.2%
813,169
+913.4%
1.17%
+1116.7%
Q3 2013$2,199,00080,2380.10%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders